Table 5 Selected studies analyzing tumor budding, depth of submucosal invasion, tumor grade, and lymphatic invasion in pT1 carcinomas
Study | Number of tumors analyzed (number with lymph node metastasis) | High tumor budding % in node-negative vs % in node-positive cases (definition of high tumor budding) | Depth of submucosal invasion % in node-negative vs % in node-positive cases | Unfavorable histological grade % in node-negative vs % in node-positive cases (features considered unfavorable) | Lymphatic invasion % in node-negative vs % in node-positive cases |
---|---|---|---|---|---|
Ueno et al8 | 251 (33) | 10 vs 49% (P<0.0001; ⩾5 per 0.75 mm2) | Using ⩾2000 μm 52 vs 91% (P<0.0001) | 24 vs 70% (P<0.0001; high-grade, mucinous) | 24 vs 70% (P<0.0001) |
Nakadoi et al9 | 499 (41) | 8.3 vs 36.6% (P<0.0001; ⩾5 per × 20 objective) | Using ⩾1800 μm 48 vs 83% (P<0.0001) | 3 vs 15% (P=0.00016; high-grade, mucinous) | 42 vs 75% (P=0.00011) |
Tateishi et al11 | 322 (46) | 28 vs 61% (P<0.01; ⩾5 per 0.75mm2) | Using ⩾1000 μm 88 vs 98% (P=0.05) | 19 vs 50% (P<0.01; moderate and poorly differentiated) | 18.5 vs 54.3% (P<0.01) |
Kawachi et al4 | 806 (97) | 25 vs 60.8% (P<0.0001; ⩾5 per 0.95mm2) | Using ⩾1000 μm 76 vs 96% (P<0.0001) | 2 vs 6% (P=0.01; high-grade, mucinous) | 30 vs 52% (P<0.0001) |
Oka et al7 | 118 (13) rectal only | 11 vs 54% (P=0.0006; ⩾5 per × 20 objective) | Using ⩾1000 μm 73 vs 92% (P=0.18) | 1.9 vs 7.7% (P=0.30; high-grade, mucinous) | 53 vs 62% (P=0.42) |
Ueno et al (30 hospital consortium)12 | 3556 (393) | 14 vs 37% (P<0.0001; ⩾5 per 20X objective) | Using ⩾1000 μm 84 vs 95% (P<0.0001) | 1.1 vs 7.6% (P<0.0001; high-grade, mucinous) | 35 vs 69% (P<0.0001) |
Pai et al 2016 (current study) | 116 (28) | 19 vs 57% (P=0<0.001; ⩾5 per 0.95 mm2) | Using ⩾1000 μm 60 vs 81% (P=0.04) | 6 vs 18% (P=0.04; high-grade) | 14 vs 39% (P=0.003) |